Resistance of Streptococcus pneumoniæ to penicillin. Clinical and epidemiological aspects;Resistencia de Streptococcus pneumoniæ a penicilina y su asociación con factores clínicos y epidemiológicos

Revista Medica de Chile

Volumn 130, Issue 1, 2002, Pages 26-34

  Contreras M, Lily ^a,b   Fica C, Alberto ^b   Figueroa C, Oscar ^b   Enríquez O, Nancy ^b   Urrutia H, Paula ^b   Herrera L, Patricio ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Penicillin resistance; Pneumococcal infections; Streptococcus pneumoni

Indexed keywords

CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; INFANT; MALE; MICROBIOLOGICAL EXAMINATION; NEWBORN; PENICILLIN RESISTANCE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0036366945     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. LEVINE MM, LAGOS R, LEVINE OS, HEITMANN I, ENRÍQUEZ N, PINTO ME ET AL. Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country. Pediatr Infect Dis J 1998; 17: 287-93.
2. INOSTROZA J, TRUCCO O, PRADO V, VINET AM, RETAMAL G, OSSA G ET AL. Capsular serotype and antibiotic resistance of Streptococcus pneumontœ isolates in two Chilean cities. Clin Diagn Lab Immunol 1998; 5: 176-80.
3. CHANDY J. Treatment failure with use of a third generation cephalosporin for penicillin resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994; 18: 188-93.
4. HEITMANN I. Epidemiología nacional de las infecciones causadas por Streptococcus pneumoniœ. Rev Chil Infect 1999; 16: 133-6.
5. KAPLAN SL, MASON JR EO. Management of infectious due to antibiotic-resistant Streptococcus pneumoniœ. Clin Microbiol Rev 1998; 11: 628-44.
6. DEEKS SL, PALACIO R, RUVINSKY R, KERTESZ DA, HORTAL M, ROSSI A ET AL. Risk factors and course of illness among children with invasive penicillin resistant Streptococcus pneumoniœ. The Streptococcus pneumoniœ working group. Pediatrics 1999; 103: 409-13.
7. FEIKIN DR, SCHUCHAT A, KOLCZAK M, BARRETT NL, HARRISON LH, LEFKOWITZ L ET AL. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90: 223-9.
8. BRADLEY JS, KAPLAN SL, KLUGMAN KP, LEGGIADRO RJ. Consensus: management of infections in children caused by Streptococcus pneumoniœ with decreased susceptibility to penicillin. Pediatr Infect Dis J 1995; 14: 1037-41.
9. TAN T, MASON E, KAPLAN S. Penicillin resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics 1993; 92: 761-7.
10. KRISTINSSON K. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist 1997; 3: 117-23.
11. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement. Document M100/S9. Wayne, Pennsylvania; 1999.
12. GARCÍA P, JULIET C. Recomendaciones para el estudio de susceptibilidad in vitro de Streptococcus pneumoniœ. Rev Chil Infect 2000; 17: 153-7.
13. AMERICAN ACADEMY OF PEDIATRICS, COMMITTEE ON INFECTIOUS DISEASES. Therapy for children with invasive pneumococcal infections. Pediatrics 1997; 99: 289-99.
14. KERTESZ D, DI FABIO JL, BRANDILEONE MC, CASTAÑEDA E, ECHANIZ-AVILES G, HEITMANN I ET AL. Invasive Streptococcus pneumoniœ infection in Latin American children: results of the Pan American Health Organization surveillance study. Clin Infect Dis 1998; 26: 1355-61.
15. TOMASZ A, CORSO A, SEVERINA EP, ECHANIZ-AVILES G, DECUNTO-BRADILONE MC, CAMOU T ET AL. Molecular epidemiologic characterization of penicillin resistant Streptococcus pneumoniœ invasive pediatric isolates recovered in six Latin American countries: an overview. Microb Drug Resist 1998; 4: 195-207.
16. BLACK S, SHINEFIELD H, FIREMAN B, LEWIS E, RAY P, HANSEN J ET AL. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19: 187-95.
17. HAUSDORFF W, BRYANT J, PARADISO P, SIBER G. Which pneumococcal serogroups cause the most invasive disease?: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30: 100-21.
18. SLEEMAN K, KNOX K, GEORGE R, MILLER E, WAIGHT P, GRIFFITHS D ET AL. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis 2001; 183: 239-46.